3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Gliosarcoma
1
Glioblastoma
1
Interventions
pembrolizumab
210
Cyclophosphamide
123
Nivolumab
108
Carboplatin
92
fludarabine
82
Gemcitabine
77
Specimen Handling
74
Bevacizumab
72
venetoclax
70
Injections
70
Magnetic Resonance Spectroscopy
67
Dexamethasone
66
Paclitaxel
65
Biopsy
59
atezolizumab
56
Cisplatin
55
Ipilimumab
50
Temozolomide
45
Docetaxel
43
Azacitidine
42
Oxaliplatin
41
Lenalidomide
41
Pemetrexed
40
Fluorouracil
40
Rituximab
39
Radiotherapy
39
Cetuximab
37
Capecitabine
37
durvalumab
36
Cytarabine
36
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Sonication
×
1 year
×
Clear all
NCT04528680
2026-04-13
SC9/ABX
Northwestern University
Phase 1/2
Active not recruiting
57 enrolled